European Medicines Evaluation Agency (EMEA) Company Profile

20:12 EST 15th December 2018 | BioPortfolio

European Medicines Evaluation Agency (EMEA)


7 Westferry Circus
Canary Wharf
E14 4H
United Kingdom


Phone: +44 (0)20 74188400
Fax: +44 (0)20 74188416

News Articles [2564 Associated News Articles listed on BioPortfolio]

New Filings At The EMA

New medicines under evaluation at the European Medicines Agency.    

European drug agency loses 30% of staff in planned move to Amsterdam

The European Medicines Agency (EMA) is counting the cost of the UK’s decision to leave the European Union, which is forcing the agency to relocate to Amsterdam.More staff than expected have left the...

European Medicines Agency Authorizes Deferral of Paediatric Investigation Plan for Trogarzo

Theratechnologies (TSX:TH) announced that the Paediatric Committee of the European Medicines Agency has accepted to defer the initiation of the Paediatric Investigation Plan for Trogarzo after the app...

European Medicines Agency Validates Marketing Authorization Application for Trogarzo

Theratechnologies (TSX:TH) is pleased to announce that the European Medicines Agency has confirmed the validity of the marketing authorization application for Trogarzo (ibalizumab) filed on August 28,...

European Medicines Agency Scales Back In Preparation for Brexit

As Britain’s “Brexit” from the European Union moves closer and closer, the European Medicines Agency (EMA), the equivalent to the U.S. Food and Drug Administration (FDA), temporary halted some o...

Alexion Submits MAA For ALXN1210 To European Medicines Agency

WASHINGTON (dpa-AFX) - Alexion Pharmaceuticals, Inc. (ALXN) announced Thursday the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for ALXN1210, it...

First two CAR-T cell medicines recommended for approval in the European Union

The European Medicines Agency (EMA) has recommended the first two marketing authorisations for chimeric antigen receptors (CAR) T-cells medicines in the European Union (EU). Kymriah (tisagenlecleucel...

Alexion Submits MAA For ALXN1210 To European Medicines Agency - Quick Facts

Alexion Pharmaceuticals, Inc. (ALXN) announced Thursday the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for ALXN1210, its investigational long-acti...

Drugs and Medications [186 Associated Drugs and Medications listed on BioPortfolio]

Terbinafine hydrochloride [Aurobindo Pharma Limited]

These highlights do not include all the information needed to use terbinafine hydrochloride safely and effectively. See full prescribing information for terbinafine hydrochloride tablets.Terbinafine H...

Cimetidine [Walgreen Company]

Walgreen Co. Cimetidine 200 Drug Facts

Dg health heartburn relief [Dolgencorp, LLC]

Dolgencorp, LLC Heartburn Relief Drug Facts

Acid reducer [Rite Aid Corporation]

Rite Aid Corporation Acid Reducer Drug Facts

Smart sense acid reducer [Kmart Corporation]

Kmart Corporation Acid Reducer Drug Facts

PubMed Articles [2759 Associated PubMed Articles listed on BioPortfolio]

Administration of mycophenolic acid is not associated with malformations in descendants from kidney transplanted males.

In pregnant women, the use of Mycophenolic acid (MPA) is associated with teratogenicity. Recently, the European Medicines Agency (EMEA) and the Spanish Agency of Medicine and Sanitary Products (AEMPS)...

Impact of Brexit on UK and EU Drug Regulation and Patient Access.

The chronology of U.K. leaving the European Union Is presented together with its implications for medicines regulation, including the move of the European Medicines Agency from London to Amsterdam, Th...

The European Medicines Agency and Family Doctors.

What to Know About Medicines With New Active Ingredients Approved in FY 2016 / 2016 in Japan and EU: A Brief Comparison of New Medicines Approved in Japan and the EU in 2016.

The Pharmaceuticals and Medical Devices Agency (PMDA) in Japan and the European Medicines Agency (EMA) have a long-standing experience of reviews of new medicines, and they meet their target pre-marke...

Marketing authorisation applications submitted to the European Medicines Agency by small and medium-sized enterprises: an analysis of major objections and their impact on outcomes.

Small and medium-sized enterprises (SMEs) are an important source of innovative medicines. Compared with their larger counterparts, they experience challenges as a result of insufficient human and fin...

Clinical Trials [2454 Associated Clinical Trials listed on BioPortfolio]

Post-Authorization Safety Study of GSK Biologicals' Pandemic Influenza Vaccine (H1N1) in the United Kingdom

The focus of this study is to assess the safety of GSK's H1N1 vaccine in real life conditions as soon as the vaccine is used, in a mass vaccination programme, and with a system for rapid g...

PENTA Fosamprenavir Study

Twice daily fosamprenavir, in combination with low dose ritonavir (FPV/RTV BID), is indicated for the treatment of HIV-infected adults, adolescents and children of 6 years of age and above...

A Non-interventional Study to Identify the Patients With Severe Luteinizing Hormone Deficiency in the Daily Practice

This non-interventional study is planned to identify the subjects with severe luteinizing hormone (LH) deficiency in the daily practice. The results will be used for the "Periodic Safety U...

Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

The purpose of this study is to show that vaccination with a single dose of GSK Biologicals' pandemic H1N1 vaccine results in an immune response that meets or exceeds European Medicines Ag...

Single-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric Subjects

This study is to identify the preferred vaccine dosage (of antigen and adjuvant) and schedule (one or two administrations) of the cell-derived H1N1sw monovalent vaccine in healthy children...

Companies [1911 Associated Companies listed on BioPortfolio]

European Medicines Agency

European Medicines Agency (EMEA) is a decentralised body of the European Union with headquarters in London.ts main responsibility is the protection and promotion of public and animal health, through t...

European Medicines Evaluation Agency (EMEA)

European Medicines Evaluation Agency (EMEA)

European Generic medicines Association

The EGA is the official representative body of the European generic pharmaceutical industry, which is at the forefront of providing high-quality affordable medicines to millions of Europeans and stimu...

European Directorate for the Quality of Medicines

The EDQM was created in 1996 and is a Directorate of the Council of Europe. Its premises have been especially designed for its various activities. Today the EDQM is organised into nine administrative...

Australia New ZealandTherapeutic ProductsAuthority

The trans Tasman therapeutic products agency project has involved New Zealand and Australia giving consideration to establishing a joint agency to regulate therapeutic products (medicines, medical dev...

More Information about "European Medicines Evaluation Agency (EMEA)" on BioPortfolio

We have published hundreds of European Medicines Evaluation Agency (EMEA) news stories on BioPortfolio along with dozens of European Medicines Evaluation Agency (EMEA) Clinical Trials and PubMed Articles about European Medicines Evaluation Agency (EMEA) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of European Medicines Evaluation Agency (EMEA) Companies in our database. You can also find out about relevant European Medicines Evaluation Agency (EMEA) Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record